Pudendal Nerve Block: Diagnosis First, Treatment Second

Pudendal neuralgia is a diagnosis patients often arrive with after years of being told nothing is wrong. The pudendal nerve carries sensation from the perineum, genitals and anal region, and when it is compressed or irritated the resulting pain is positional in a way that is almost diagnostic on its own: worse sitting, relieved standing, and typically absent when lying down.

The block has two distinct jobs here — confirming the diagnosis and treating it — and the evidence is much stronger for the first than the second. This reference sets out the anatomy, the criteria that make the diagnosis defensible, and what the recent randomised evidence says about the block’s place. It sits under our clinical reference to nerve blocks in outpatient pain practice.

The nerve, and the two places it gets caught

The pudendal nerve arises from the S2 to S4 sacral roots, leaves the pelvis through the greater sciatic foramen, passes between the sacrospinous and sacrotuberous ligaments, and re-enters through the lesser sciatic foramen to run in Alcock’s canal — a fascial tunnel on the medial aspect of the obturator internus.

Those are the two classical entrapment sites: the interligamentous space and Alcock’s canal. A 2026 systematic review of ten studies, including cadaveric series and imaging work, argued that entrapment within Alcock’s canal is best understood as a compartment-like syndrome, in which repetitive mechanical stress, fascial constriction and impaired venous drainage produce ischaemic neuropathy rather than simple mechanical compression.

That framing has practical value. It explains why the pain is positional, why prolonged sitting and cycling are consistent aggravators, and why the condition progresses if the mechanical cause is not addressed.

The Nantes criteria

Pudendal neuralgia is a clinical diagnosis, and the reference standard is the Nantes criteria. Their essential elements are pain in the territory of the pudendal nerve, pain worsened by sitting, pain that does not wake the patient at night, no objective sensory loss on examination, and relief from a diagnostic pudendal nerve block.

Two of those deserve emphasis because they are the ones most often overlooked. Pain that reliably wakes the patient from sleep argues against the diagnosis. And objective sensory loss suggests a different or additional lesion, because pudendal neuralgia is a pain syndrome rather than a sensory-deficit syndrome.

The block is therefore not confirmatory on its own — it is one criterion among several, and a positive block in a patient who fails the other criteria does not establish the diagnosis. MR neurography has been added to the diagnostic picture in recent work, though the same review noted substantial heterogeneity and small samples across the evidence base.

What the block achieves, and a comparison worth knowing

The most informative recent evidence is a 2026 prospective, randomised, double-blinded trial in 90 patients with pudendal neuralgia, which compared a catheter-based pudendal nerve block against a catheter-based sacral nerve block through the third posterior sacral foramen. Both groups had a catheter left in place for seven days with a daily bolus of 0.2% ropivacaine and betamethasone on day seven.

The sacral block outperformed the pudendal block at every time point: lower pain scores at one, three and six months, more patients reporting excellent or good outcomes at six months (75.6% against 37.5%), and a substantially longer maximum sitting time at six months (68.6 minutes against 37.7). No severe complications occurred in either arm.

The authors’ explanation is anatomically sensible: broader S2 to S4 coverage addresses the nerve at root level and may reach central sensitisation that a distal block does not. The practical implication for a pain practice is that a pudendal block which produces diagnostic confirmation but disappointing therapeutic durability is behaving as the literature predicts, and that a more proximal approach is a recognised next step rather than an improvisation.

Note the design when quoting these numbers: this was a catheter technique with seven days of infusion, not a single injection, and the results should not be transferred to single-shot practice.

When decompression enters the picture

Surgical decompression showed variable but often favourable outcomes across the 2026 review, with the same caveats of heterogeneity and absent standardised outcome measures. The block’s role in that pathway is prognostic: a patient who obtains clear, if temporary, relief from a well-placed block has demonstrated that the nerve is the pain generator.

That is the same logic that governs diagnostic blocks elsewhere in the spine, and it carries the same hazard — the false positive. A single positive block in a chronic pain population is weaker evidence than it appears.

Safety

The pudendal nerve runs alongside the pudendal artery and vein, which makes vascular puncture and intravascular injection the principal technical concerns, and the deep location means systemic absorption is not trivial. Image guidance — ultrasound, fluoroscopy or CT depending on approach — is standard rather than optional.

Patients should be warned that transient weakness or numbness in the perineum, and temporary difficulty with continence or sexual sensation, can follow a successful block. The general safety architecture for any block, including local anaesthetic systemic toxicity and the anticoagulation documents that are commonly confused, is in the nerve blocks reference.

For clinicians

This is a deep block in a region where the landmarks are not palpable and the vascular anatomy is immediate, so it is learned under supervision with imaging. This reference carries no needle depths or trajectories.

What ultrasound guidance does and does not improve is covered in musculoskeletal ultrasound for pain practice. Empire teaches ultrasound-guided peripheral and sympathetic blocks within Advanced Musculoskeletal Ultrasound Guided Injections, part of the pain management academy.